Skip to content

Insider · CIK 0001954272

Bradley M. Nagel

cfoofficer

Files at ELMD (Electromed, Inc.). First filing Jun 8, 2026, latest Jun 8, 2026.

Bradley M. Nagel files SEC Form 4 as CFO at ELMD (Electromed, Inc.). Since Jun 8, 2026, Bradley M. Nagel has reported 0 open-market buys worth $0 and 1 open-market sell worth $429k, the latest filed on Jun 8, 2026.

A track record needs three past buys with six months of prices behind them; Bradley M. Nagel has 0, so none is measured yet.

The newest scored trade: sold $429k of ELMD on Jun 4, 2026, filed Jun 8, 2026, scored 42 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $429k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $429k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ELMD: Electromed, Inc.

ELMDOct 9, 2026 · close 27.69

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
42Moderate
ELMDsell 2
Electromed, Inc.
$429k
11,801 shares
-38%+103% from low-7% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 4, 2026 ELMD
Electromed, Inc.
11,801
0.14% of outstanding
$429kJun 4, 2026none

Transactions

Every row this insider has filed, 12 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026ELMD
Electromed, Inc.
AGrant or award
Common Stock
+4,900$0.00$023,86440 d ago
Sep 1, 2026ELMD
Electromed, Inc.
FTax withholding
Common Stock
-1,102$27.10$30k22,76240 d ago
Sep 1, 2026ELMD
Electromed, Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+9,600$0.00$09,60040 d ago
Jun 4, 2026ELMD
Electromed, Inc.
MOption exercise
Common Stock
+4,334$10.25$44k26,172Jun 8, 2026
Jun 4, 2026ELMD
Electromed, Inc.
MOption exercise
Common Stock
+5,267$10.71$56k31,439Jun 8, 2026
Jun 4, 2026ELMD
Electromed, Inc.
SOpen-market sale
Common Stock
-11,620$36.34$422k19,819Jun 8, 2026
Jun 4, 2026ELMD
Electromed, Inc.
SOpen-market sale
Common Stock
-181$37.11$6,71819,638Jun 8, 2026
Jun 4, 2026ELMD
Electromed, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative
-4,334$0.00$02,166Jun 8, 2026
Jun 4, 2026ELMD
Electromed, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative
-5,267$0.00$02,633Jun 8, 2026
Sep 2, 2025ELMD
Electromed, Inc.
FTax withholding
Common Stock
-562$23.95$13k16,538Sep 4, 2025
Sep 2, 2025ELMD
Electromed, Inc.
AGrant or award
Common Stock
+5,300$0.00$021,838Sep 4, 2025
Sep 2, 2025ELMD
Electromed, Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+9,800$0.00$09,800Sep 4, 2025

Questions about Bradley M. Nagel

Answered from the filings on this page, as of the latest one.

Is Bradley M. Nagel buying or selling?

In the last 12 months Bradley M. Nagel reported 0 open-market buys worth $0 and 1 open-market sell worth $429k on SEC Form 4; the latest was sold $429k of ELMD on Jun 4, 2026. Grants, option exercises and tax withholding are not counted.

How did Bradley M. Nagel's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bradley M. Nagel has 0.

Where does Bradley M. Nagel file Form 4?

Bradley M. Nagel has filed Form 4 at ELMD (Electromed, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.